T he transporter associated with Ag processing (TAP) 3 transports cytosolic peptides, predominantly generated by the proteasome into the endoplasmic reticulum (ER) (1). There, they are loaded onto newly synthesized MHC class I (MHC I) that transiently associates with TAP and accessory chaperones to form the MHC I peptide-loading complex (PLC) (1).
T he transporter associated with Ag processing (TAP) 3 transports cytosolic peptides, predominantly generated by the proteasome into the endoplasmic reticulum (ER) (1) . There, they are loaded onto newly synthesized MHC class I (MHC I) that transiently associates with TAP and accessory chaperones to form the MHC I peptide-loading complex (PLC) (1) .
Tapasin, a type I transmembrane glycoprotein, is believed to play a key role in the formation of the PLC because it binds to MHC I molecules (2) as well as to the transmembrane domains (TMDs) of the TAP subunits, TAP1 and TAP2 (3) . In the absence of tapasin the stability of MHC I-peptide complexes is drastically reduced (4) and the repertoire of surface-presented peptide Ags is altered (5) , suggesting that tapasin acts as an editor that selects peptides for stable binding onto MHC I (6) . Importantly, loading of MHC I with peptide Ags conferring high stability requires the tapasin-mediated introduction of TAP into the PLC, whereas the mere interaction of MHC I with tapasin is not sufficient (7) . However, whether the close proximity between MHC I and TAP in the PLC, as such, favors tapasin-mediated quality control of MHC I loading by high local peptide concentration or whether the interaction of tapasin with TAP1 and/or TAP2 has a more specific function in the process of MHC I loading is not known.
A current study showed that coexpression of truncated TAP chains lacking the N-terminal 4 and 3 transmembrane helices in TAP1 and TAP2 results in an active peptide transporter that is deficient in tapasin association (8) . Because the TMDs of TAP1 and TAP2 were shown to bind tapasin independently from each other (3) , it was reasoned that the interaction of tapasin with TAP occurs exclusively via the N-terminal regions (N domains) of both TAP subunits.
To investigate whether and to what extent the N domains of TAP are required for intracellular processing and surface expression of MHC I, we stably expressed truncated TAP subunits in combination with corresponding wild-type TAP chains, as headto-tail fusion proteins or as single chains in the human TAP-negative cell line T2. We show that the N domains of both TAP subunits operate as separate tapasin binding sites in the PLC. At any given time only one of two N domains appears to be actively involved in the tapasin-mediated interaction with newly synthesized MHC I. However, neither N domain is required for ER export and surface presentation of MHC I. Moreover, depending on the assembly state of TAP1, different subregions of its TMD are used for tapasin-binding. Heterodimeric assembly of the TAP subunits is accompanied by a displacement of tapasin from the coreTMD to the N domain in TAP1, whereas TAP2 interacts with tapasin exclusively via the N domain.
An important finding of our work is that TAP variants lacking the N domain in TAP2, but not in TAP1, form PLCs that are disturbed in the physical interaction with calreticulin (Crt), calnexin (Cnx), and ER60 and the quality control of MHC I loading. This suggests that TAP1 and TAP2 differ in the structural requirements for stable recruitment of accessory chaperones and that the tapasin-docking site of TAP2 plays a pivotal role in the functional integrity of the PLC. In a situation where the quality control function of the PLC fails, a post-ER mechanism rescues stable peptideloading and surface expression of MHC I. Most interestingly, our findings suggest that this depends on the catalytic activity of proprotein convertases (pPCs) that reside in compartments of the late exocytic route (9) and contribute to the proteolytic generation of CTL-epitopes (10) .
The results of this report extend our knowledge on the function of the PLC and contribute to the understanding of the intracellular maturation of MHC I molecules in the ER and post-ER compartments.
Materials and Methods

Cell lines and cell culture
T2 is a human lymphoblastoid cell line deficient for TAP and expresses HLA-A2 and HLA-B5 (11) . Transfectants of T2 expressing rat TAPwt or truncated rat TAPs were cultured in IMDM (Invitrogen Life Technologies) supplemented with 1 mg/ml G418 (PAA Laboratories) (12) . Murine TIB-75 hepatocytes (13) were cultured in DMEM (Invitrogen Life Technologies).
Cloning and expression of truncated TAPs
The vector pBLKSII ϩ (Stratagene) containing rat TAP1 a cDNA (14) or rat TAP2 a cDNA (15) was subjected to QuikChange site directed mutagenesis (Stratagene) using primers 5Ј-GCGCACGCTCGATGCCCTCCGGACA CAAGGGCGCTGG-3Ј and 5Ј-CCAGCGCCCTTGTGTCCGGAGGGCAT CGAGCGTGCGC-3Ј or primers 5Ј-CGCAGACCCCACCATGCCCG GG CAGGAGAATAACAGAGC-3Ј and 5Ј-GCTCTGTTATTCTCCTGCCC GGGCATGGTGGGGTCTGCG-3Ј to generate 1⌬N (TAP1 ⌬2-139 ) or 2⌬N (TAP2 ⌬2-128 ) before cloning into pH␤Apr1neo (16) . Constructs were transfected into T2 cells by electroporation using a Bio-Rad gene pulser at 270 V and 500 F. For cloning of the two tandem TAPs the 3269-bp ScaI/Acc65I fragment from the pBLKSII ϩ derivative pBL2⌬N was ligated to either the 4385-or the 3971-bp fragment from a ScaI/BsrGI digest of pBLKSII ϩ containing TAP1 or 1⌬N. From the resulting plasmids the 7088-or 6674-bp AgeI/BbvCI fragment was ligated to the AgeI/BbvCI fragment containing the connector region of murine multidrug resistance protein MDR1b (17) (see below). These constructs encoding tandem TAP TD1/2⌬N (TAP1-MDR1b 640 -701 -TAP2 ⌬2-139 ) or TD1⌬N/2⌬N (TAP1 ⌬2-139 -MDR1b 640 -701 -TAP2 ⌬2-139 ) were cloned into pH␤Apr1neo and transfected into T2 cells. The multidrug resistance protein 1b (MDR1b) connector region was cloned by RT-PCR. mRNA was prepared from TIB-75 hepatocytes using RNeasy and Oligotex kits (Qiagen). RT-PCR and subsequent PCR were performed in combination with MDR1b-specific primers 5Ј-CCCCTACAATCCTTGAAAATACTATGGC-3Ј, 5Ј-CCCCTAC AATCCTTGAAAATACTATGGC-3Ј, and 5Ј-GGTGGTGTCATTGTG-GAGCAAGG-3. The resulting 403-bp fragment of MDR1b was cleaved with SacI and HinP1I and ligated with SacI/AccI-digested pBLKSII ϩ . This vector served as template for a further PCR using the primers 5Ј-TGTTA CCGGTCCATGGTGGAGGCTCTTGCGGCTCCTTCAGACCCAGGAA ATAATGCTTATGGATCCC-3Ј and 5Ј-ATCCGGCTTGGACAGCCTCA GCAACCGCCAAAAGGAAACCAGAGGC-3Ј to generate a TAP-MDR1b-chimeric 227-bp fragment that was ligated with the AgeI/BbvCI fragments derived from the tandem precursor plasmids (see above). All TAP constructs were fully sequenced.
Antibodies
116/5 and D90 are rabbit antisera recognizing the C terminus of rat TAP2 (18) or rat TAP1 (15) . 3B10.7 is a rat mAb binding the H chains of HLA-A and -B (19) . 4E is a ␤ 2 m-dependent mouse mAb that recognizes an epitope common to all assembled HLA-B molecules (20) . ␣ER60 (21) and R.gp48N (22) are rabbit antisera binding ER60 or tapasin. SPA-600 and -865 are rabbit antisera recognizing Crt or Cnx (StressGen Biotechnologies).
Pulse-chase analysis, immunoprecipitation, endoglycosidase H (endo H) assay, Western blotting, and peptide cross-linking
Cells were starved for 2 h in methionine/cysteine-free RPMI 1640. A total of 500 Ci of Promix (Amersham Biosciences) was added for 30 or 60 min. The chase was initiated by the addition of a 10-fold excess of unlabeled methionine/cysteine. Equal number of cells were lysed in PBS containing 1% digitonin (WAKO) or 1% Triton X-100 (Sigma-Aldrich). Immunoprecipitations were performed from equivalent amounts of precleared lysates by using anti-TAP2 or anti-MHC I Abs. For identification of coisolated MHC I, precipitated complexes were separated by SDS-PAGE. Fluorographs were scanned by a Chromoscan 3 microdensitometer (JoyceLoebl). Immunoprecipitation, endo H assay, Western blotting, and peptide cross-linking were performed as described earlier (12) .
Flow cytometry
Flow cytometry was performed as described previously (12) . To investigate heat sensitivity of MHC I, transfectants were incubated for 10 min at 4°C, 40°C, 50°C, and 60°C. To analyze the thermostability of intracellular HLA-B5, cells were fixated in 0.5% paraformaldehyde before permeabilization in PBS containing 0.5% saponin/0.5% BSA and incubation with mAb 4E. Before addition of FITC-coupled anti-mouse IgG, cells were washed with PBS containing 0.5% saponin/0.5% BSA. To determine thermostability of surface HLA-B5, cells were directly immunostained with mAb 4E without fixation and permeabilization.
To characterize MHC I processing, primaquine (Sigma-Aldrich) or NH 4 Cl were applied for 3 or 18 h at a concentration of 250 M or 20 mM. Hexa-D-arginine (Calbiochem) was added at different concentrations for 14 h at 37°C after removal of surface MHC I by 3 min incubation with 50 mM citrate (pH 3) and subsequent neutralization of pH.
Peptide transport assay
The peptide transport assay was performed as described previously (12) . To directly compare the transport activities of TAPwt and truncated TAPs we normalized the results of the transport assays for the expression levels of the different transporters. For quantification of TAP steady-state levels, equivalent numbers of cells were lysed in 1% Triton X-100. Lysates were serially diluted 2-fold and separated by SDS-PAGE. Western blots were probed for TAP1 and TAP2. Densitometric scanning revealed almost identical expression levels for TAPwt, 1-2⌬N, and 2-1⌬N. In the case of TD1/ 2⌬N and TD1⌬N/2⌬N, the TAP steady-state expression levels were 10-fold lower compared with that in T2(TAPwt).
Results
ER-export and surface expression of MHC class I does not depend on the number and position of tapasin-docking sites in TAP
To investigate the function of the N domains in TAP for MHC I processing, we stably coexpressed rat TAP1, lacking residues 2-139 (1⌬N) or rat TAP2, lacking residues 2-128 (2⌬N) (Fig. 1A) with the corresponding wild-type TAP chain in T2 cells. The respective transporters were named 2-1⌬N and 1-2⌬N. Surprisingly, transfectants coexpressing 1⌬N and 2⌬N could not be established, although Ͼ100 different cell lines from four independent transfections were analyzed (data not shown). This suggests that stable expression of a heterodimeric TAP variant lacking both N domains is either harmful to the transfected T2 cell or that the transporter is structurally unstable and rapidly degraded. Nevertheless, 1-2⌬N and 2-1⌬N are expressed at levels comparable to TAPwt (Fig. 1B) . Furthermore, studies on peptide binding (Fig. 1C) and transport ( Fig. 1D) using radiolabeled model peptides demonstrate efficient transport function for 1-2⌬N and 2-1⌬N.
Based on structural data of ATP-binding cassette transporters (23), we speculated that the N domains of TAP1 and TAP2 point in the heterodimeric transporter to opposite sides of the paired coreTMDs and act as two autonomous tapasin-docking sites for the transient interaction with MHC I. To investigate this, we analyzed the ability of the truncated TAPs to interact with tapasin and MHC I by immunoisolation of TAP or MHC I from digitoninlysed cells ( Fig. 2A) . Both truncated TAPs retain the ability to form complexes with tapasin and MHC I. However, anti-TAP immunoprecipitations show that tapasin-interaction is reduced in the truncated TAP variants by ϳ50% when compared with TAPwt. In contrast, the amounts of MHC I coprecipitated with TAP are almost identical for the different transporter variants indicating that MHC I interaction is comparable in TAPwt, 1-2⌬N and 2-1⌬N. In accordance with this, pulse-chase experiments (Fig. 2B ) revealed that the half-life of interaction between newly synthesized MHC I and truncated TAP variants is very similar to that observed for the wild-type PLCs (Ϸ100 min). Thus, despite reduced tapasin-binding, the PLCs formed by 1-2⌬N and 2-1⌬N show a normal transient interaction with peptide-receptive MHC I. We next compared the intracellular processing ( Fig. 2C ) and surface expression ( (Fig. 2D) . Thus, neither the N domain of TAP1 nor the N domain of TAP2 is required for ER-export and surface expression of MHC I. Moreover, our data provide evidence that TAPwt, 1-2⌬N, and 2-1⌬N do not differ in the transient recruitment of MHC I for peptide loading.
Head-to-tail-fusion of TAP chains allows stable expression of transporters lacking both N domains
We next asked whether the construction of a TAP-fusion protein could solve difficulties to stably coexpress 1⌬N and 2⌬N. Therefore, we used the tandem structure of the P-glycoprotein as template for a head-to-tail fusion of 1⌬N and 2⌬N linked by the connector region of murine MDR1b (17) (Fig. 3A) . In addition, a second TAP-fusion construct was made containing TAP1 instead of 1⌬N. The resulting tandem TAPs, TD1⌬N/2⌬N and TD1/2⌬N, which were stably expressed in T2 cells (Fig. 3B) show a subcellular localization comparable to TAPwt (data not shown). For functional characterization we analyzed peptide binding ( Fig. 3C ) and translocation (Fig. 3D ). Both tandem variants show detectable peptide cross-linking, suggesting that they contain functional substrate binding sites. Moreover, the transport activities obtained for TD1/2⌬N and TD1⌬N/2⌬N (Fig. 3D) are roughly within the range of TAPwt when normalized for the expression levels of the different TAP variants. Variant TD1/2⌬N is somewhat less active while variant TD1⌬N/2⌬N is slightly more active than the wildtype transporter. Thus, TAP variants lacking the N domains in both To analyze the PLCs formed by tandem TAPs, we immunoisolated TAP or MHC I from digitonin-lysed cells and analyzed coisolated polypeptides by Western blot. As with 1-2⌬N ( Fig. 2A) , the related transporter TD1/2⌬N retains tapasin-and MHC I-binding, whereas TD1⌬N/2⌬N, which lacks both N domains, is completely excluded from the PLC (Fig. 4A) . We next investigated whether TD1/2⌬N and TD1⌬N/2⌬N deliver peptides for loading of MHC I. Because the expression levels of the tandem TAPs are lower than the expression levels of TAPwt (Fig. 3B) , the cell lines T2(TD1/2⌬N) and T2(TD1⌬N/2⌬N) display only a partial restoration of intracellular processing (Fig. 4B ) and surface expression (Fig. 4C ) of MHC I. However, despite the differences in the tapasin/MHC I recruitment by the two tandem TAPs, T2(TD1/2⌬N) and T2(TD1⌬N/2⌬N) show very similar steady-state distributions of ER and post-ER MHC I (Fig. 4B ) and comparable amounts of surface HLA-B5 (Fig. 4C ). This implies that under conditions, in which physical interaction between TAP and tapasin is impaired, newly synthesized MHC I molecules can take alternative routes of peptide-loading outside the TAP-associated PLC as long as suitable peptides are delivered by a functional transporter.
Assembled and nonassembled TAP1 uses different TMD subregions for tapasin binding
The interaction between tapasin and the N domains could depend on heterodimerization of TAP or might reflect an intrinsic property of the two TAP subunits. To address this, we generated T2 cells expressing 1⌬N or 2⌬N as single TAP chains. Fig. 5A shows that both have steady-state expression levels comparable to the corresponding wildtype TAP subunits. To investigate whether the truncated TAP chains retain the ability to associate with the PLC, MHC I and truncated TAP chains were immunoisolated from digitonin lysates and coprecipitated proteins were analyzed by Western blot (Fig. 5B) . In contrast to 2⌬N, which is excluded from the PLC, 1⌬N retains the full ability to interact with tapasin and MHC I, indicating that in single expressed TAP1 the coreTMD acts as sole tapasin-docking site. Because indirect immunofluorescence showed identical ER-distribution for the truncated and wild-type TAP subunits (data not shown), we can exclude that the different behavior of 1⌬N and 2⌬N is caused by a distinctive intracellular localization. Thus, our findings suggest that depending on the assembly state of TAP1 different subregions of TMD1 are used for the interaction with tapasin, whereas in TAP2 the tapasin interaction is exclusively mediated by the N domain. 
TAP variants 1-2⌬N and 2-1⌬N show different effects on the quality control of Ag presentation
MHC I-loading with peptides conferring high stability requires the tapasin-mediated introduction of TAP into the PLC (7). To investigate the role of the N domains for the quality control of MHC I loading (1), we took advantage of the correlation between the thermostability of MHC I and the affinity of their peptide cargo (6) . Therefore, lysates of the different transfectants were incubated for 1 h at 4°C or 37°C before the integrity of MHC I was tested by immunoprecipitation with the HLA-B5-specific ␤ 2 -microglobulindependent mAb 4E (20) . In cells expressing TAPwt or 2-1⌬N the majority of HLA-B5 is heat-stable whereas striking thermolability of MHC I is observed in cells expressing 1-2⌬N, the tandem TAPs or no TAP (Fig. 6A) . No temperature effects were observed in control experiments where immunoisolations were performed with the conformation-independent anti-MHC I mAb 3B10.7 (Fig. 6A) . To elucidate whether the observed thermolability of MHC I is due to suboptimal peptide binding, we preincubated the lysates with a high-affinity HLA-B5 peptide ligand before heat treatment. The Western blot in Fig. 6A shows that peptide addition significantly stabilizes HLA-B5 in cells expressing 1-2⌬N, TD1/2⌬N, TD1⌬N/ 2⌬N, or no TAP, suggesting that the presence of the N domain in TAP2 is required for optimal peptide loading and formation of stable MHC I. To validate this idea, we analyzed the thermostability of intracellular and surface HLA-B5 in intact cells by flow cytometry. For these studies we focused on T2(TAPwt), T2(1-2⌬N), and T2(2-1⌬N), which have comparable TAP expression (Fig. 1B) . Because assembled MHC I has a much higher heat resistance under physiological conditions than in detergent extracts (24) , cells were either heat-shocked for 10 min at 40°C, 50°C, or 60°C or not heat-shocked at all. Cell lines expressing TAPwt or 2-1⌬N are characterized by high thermostability of intracellular HLA-B5 whereas in nontransfected T2 cells only 20% of intracellular HLA-B5 remains stable at 40°C and Յ10% at temperatures Ͼ50°C (Fig. 6B ). In line with the results in Fig. 6A, T2(1-2⌬N) shows a remarkable thermolability of intracellular HLA-B5 at temperatures Ͼ40°C (40 -70% reduction of the immunostaining at 50°C and 60°C, respectively). Most surprisingly, all analyzed transfectants displayed a comparable high thermostability of surface HLA-B5. Accordingly, we observed that in the presence of brefeldin A, which blocks the ER/Golgi transport, the time course in the survival of surface HLA-B5 (Ϸt 1/2 ϭ 15h) is almost identical among T2(1-2⌬N), T2(2-1⌬N), and T2(TAPwt) (Fig. 6C) . Taken together, this suggests that in the cell line T2(1-2⌬N) the population of HLA-B5 on the cell surface is physically more stable than the intracellular fraction of HLA-B5.
To investigate whether stabilization of HLA-B5 occurs during the intracellular transport to the cell surface, we performed pulsechase experiments (Fig. 6D) . Cell lysates of different time points were heat-treated at 37°C for 1h in the presence or absence of MHC I-binding peptides. Thermoresistant MHC I was immunoisolated with conformation-sensitive mAb 4E and incubated with endo H. The ER-export rate of total HLA-B5 is similar in T2(TAPwt), T2(1-2⌬N), and T2(2-1⌬N) as determined in the presence of stabilizing peptide (Fig. 6D) . However, in the absence of external peptide, MHC I from T2(1-2⌬N), but not from T2(TAPwt) or T2(2-1⌬N), shows significant thermolability even after export from the ER (Fig. 6D) . Furthermore, comparison of the signals of endo H-resistant MHC I isolated in the presence or in the absence of stabilizing peptides demonstrates that in T2(1-2⌬N) the ER-exported MHC I molecules improve their thermostability during post-ER maturation. Our experiments suggest that PLCs formed by 1-2⌬N lost their quality control function in the assembly of stably loaded MHC I. Furthermore, our data provide evidence that structural stability of MHC I can be rescued in post-ER compartments of the secretory route.
Comparison of MHC class I processing in cells expressing TAP variants 1-2⌬N and 2-1⌬N
Two important questions arise from our findings. First, what is the molecular basis for the defective quality control of MHC I processing in T2 (1-2⌬N) and second, what kind of cellular mechanism leads to stabilization of surface MHC I in this cell line?
In addition to tapasin, the chaperones ER60 and Crt are thought to play a critical role in the quality control of MHC I processing (1) . Therefore, we compared the complex formation of 1-2⌬N and 2-1⌬N with ER60 and Crt by immunoprecipitation. Additionally, the association with Cnx, which is thought to be a component of a precursor complex that precedes the formation of the PLC (25), was analyzed. Fig. 7A shows comparable precipitation of TAP, proving that immunoisolations had been equally efficient. Furthermore, in accordance with the experiment shown in Fig. 2 , we observed comparable coisolation of MHC I. In support of the model that Crt becomes inserted into the PLC together with MHC I (25), we found identical amounts of this chaperone in the complexes of TAPwt and 2-1⌬N. The amount of tapasin, ER60, and Cnx coisolated with 2-1⌬N equals half the amount coisolated with TAPwt, indicating that in 2-1⌬N solely the N domain of TAP2 is involved in the formation of precursor and/or PLCs. The interaction of 1-2⌬N with tapasin and MHC I resemble the properties of complexes formed by 2-1⌬N (Figs. 2 and 7A ). However, in contrast to 2-1⌬N, the amount of chaperones coprecipitated with 1-2⌬N is significantly reduced. The amounts of ER60, Cnx, and Crt correspond to 10, 15, and 40% of that found for the complex of TAPwt. Thus, although tapasin and MHC I are efficiently recruited to the N domain of TAP1 in 1-2⌬N, the formation of precursor complexes and PLCs seems to be disturbed in the assembly of chaperones. It is reasonable to assume that this is directly responsible for the defective quality control of MHC I-loading observed in T2 (1-2⌬N) .
To determine whether the transfectants expressing 1-2⌬N gain stability of surface HLA-B5 by an increased rate of endocytic recycling and reloading of MHC I during endosomal processing, cells were treated with primaquine or NH 4 Cl (Fig. 7B) . Primaquine is a drug that causes intracellular accumulation of endocytosed proteins including MHC I, whereas NH 4 Cl blocks endosomal processing. The different transfectants show almost identical reductions of surface-exposed HLA-B5 in the presence of the lysosomotropic reagents (up to 25% for primaquine). This indicates that the cell lines do not differ in the endocytic recycling and processing of surface MHC I. Stryhn et al. (26) proposed that suboptimally loaded MHC I exchanges low affinity peptide ligands after reaching the late compartments of the exocytic route. Proprotein convertases (pPCs), which cycle between trans-Golgi network (TGN), plasma membrane and endosomes (9) have been reported to be involved in the generation of peptide Ags for MHC I (10, 27) . To test whether the high level of surface MHC I expression in cell line T2 (1-2⌬N) depends on the activity of pPCs, we performed surface MHC I-recovery experiments in the presence of increasing (43) and incubated for 1 h at 4°or 37°C. The thermostability of HLA-B5 was analyzed by immunoprecipitation using mAbs 3B10.7 or 4E (left). Precipitates were analyzed in Western blots probed with mAb 3B10.7. The obtained signals were quantified by densitometric scanning and the peak integrals were plotted in arbitrary units (right). B, Thermostability of intracellular and cell surface MHC I. Transfectants were collected in PBS/0.1% NaN 3 and incubated at 4°C, 40°C, 50°C, and 60°C for 10 min. To determine thermostability of surface HLA-B5, cells were directly immunostained with mAb 4E. For the analysis of the thermostability of intracellular HLA-B5, transfectants were permeabilized, fixated, and stained with mAb 4E. Flow cytometry was performed as described in Fig. 2D . C, Survival of MHC I molecules on the cell surface. Transfectants were treated with brefeldin A that inhibits protein export from the ER. After culturing the cells for different time points, MHC I surface staining with mAb 4E was performed. Results of the flow cytometry are presented as percentage of reduction of the mean fluorescence intensities at 1, 2, concentrations of the pPC-inhibitor hexa-D-arginine (HDA), which inhibits furin and closely related pPCs with high specificity (28) . In T2(TAPwt) and T2(2-1⌬N) the recovery of surface MHC I was not or only slightly affected. This suggests that in these two cell lines the pPC-pathway plays only a minor role in the generation of MHC I ligands (Fig. 7B) . However, T2 cells expressing 1-2⌬N show a significant and concentration-dependent reduction (up to 45% at 100 M HDA) of surface MHC I in the presence of HDA (Fig. 7B) , suggesting that a substantial amount of HLA-B5 Ags originate from proteolytic products generated by furin or related pPCs. Thus, it seems that in a situation where quality control in the PLC fails, a post-ER mechanism that depends on pPC-activity can rescue stable surface expression of MHC I.
Discussion
Optimization of peptide-loading onto MHC I requires the tapasinmediated incorporation of TAP into the PLC (7). Recent reports showed that both TAP subunits interact with tapasin (3), and that in assembled transporters the N domains of the TMDs serve as tapasin-docking sites (8) . However, the stoichiometry of the TAP/ tapasin subcomplex is controversial. The proposed number of tapasin molecules in the PLC ranges from 1 (29) to 4 (30) . Thus, it is not clear whether all tapasin-docking sites of TAP are used in the PLC for the MHC I binding at the same time. To investigate the function of the tapasin binding sites in TAP1 and TAP2 for MHC I processing, we stably expressed transporters lacking the N domains in TAP1 (2-1⌬N) or TAP2 (1-2⌬N) in the cell line T2. Pulse-chase experiments showed almost identical kinetics for the release of MHC I from TAPwt and the truncated TAPs (Fig. 2B) . This and the observation that almost equal amounts of radiolabeled MHC I were coisolated with TAPwt, 1-2⌬N, or 2-1⌬N at any time point of the pulse-chase experiment (Fig. 2B) indicates that during the chase period comparable quantities of newly synthesized radiolabeled MHC I passed through the three different PLCs. Consistently, Western blots show that under steady state conditions nearly the same amounts of MHC I bind to the PLCs of wild-type and truncated TAPs, whereas the amount of tapasin coisolated with 1-2⌬N or 2-1⌬N equals half of that associated with TAPwt (Fig.  7A) . Thus, although TAPwt has the capability to recruit MHC I via both subunits, it seems that in the functional PLC at any given time only one of two N domains is actively involved in the tapasinmediated interaction with newly synthesized MHC I. In view of the observation that the N domains of TAP1 and TAP2 function as separate tapasin-docking sites ( Figs. 2A and 7A) , it is attractive to speculate that the two TAP subunits in TAPwt normally alternate with each other in the tapasin-dependent recruitment of newly synthesized MHC I.
One of the crucial findings of this work is that T2 transfectants expressing 1-2⌬N display significant thermolability of intracellular MHC I when compared with cell lines expressing 2-1⌬N or TAPwt (Fig. 6) . In view of the well-known correlation between the thermostability of MHC I and the affinity of their ligands (6) , it is reasonable to assume that in the presence of 1-2⌬N MHC I is loaded with suboptimal peptide cargo. The observation that the truncated TAPs, 1-2⌬N and 2-1⌬N, show comparable binding of tapasin and MHC I (Fig. 7A ) excludes that the low MHC I stability in cell line T2(1-2⌬N) is due to a diminished interaction between 1-2⌬N and tapasin. Thus, the "bridging function" of tapasin, which allows the close proximity of TAP and MHC I, is apparently not sufficient for the formation of stable MHC I-peptide complexes. Most interestingly, the thermolability of MHC I in T2(1-2⌬N) correlates with a drastically reduced amount of chaperones in the 1-2⌬N-associated PLC (Fig. 7A) . Quantitative evaluation revealed that the amount of chaperones coisolated with 2-1⌬N corresponds to half the amount of auxiliary molecules associated with TAPwt whereas in the case of 1-2⌬N, the signals for the coisolated chaperones are only barely detectable. Thus, despite the normal association with tapasin and MHC I, 1-2⌬N seems to be defective in the stable recruitment of chaperones. Importantly, several studies point toward a critical role for these chaperones in the quality control of Ag presentation (31, 32) , a multifactorial process where tapasin in cooperation with ER60 and Crt improves loading of MHC I with high-affinity ligands. A recent working model postulates that tapasin and the chaperones optimize peptides for MHC I by deforming the peptide-binding pocket in a way that some stabilizing contacts to the peptide cannot be formed (1) . MHC I molecules in this conformation load only high-affinity peptides that fulfill the requirements for stable binding. In line with this view, our results suggest that PLCs formed by 1-2⌬N lost their quality control function in MHC I loading by a failure in the normal chaperone-assisted peptide editing via tapasin.
We provide evidence that the N domains of TAP1 and TAP2 have distinct requirements for stable recruitment of ER60, Crt and Cnx (Fig. 7A) and that the N domain of TAP2 plays a key role in the proper assembly of PLCs. Cnx was reported to be a component of a TAP/tapasin-containing precursor complex that precedes the entry of MHC I and Crt (25) . Thus, poor recruitment of chaperones by 1-2⌬N may reflect problems that arise early in the biosynthetic assembly of the PLC. Recent studies suggest that cooperative interactions between the chaperones are required for their stable association with the precursor complex and the PLC (25, (31) (32) (33) . However, the exact molecular basis of this phenomenon is unknown and the assembly pathway of the PLC is only partly understood. Our experiments in Figs. 4 and 5 suggest that single expressed TAP1 subunits bind tapasin solely via the coreTMD whereas free TAP2 and the assembled TAP molecules use the N domains for tapasin binding. Thus, it is reasonable to speculate that pairing of the TAP subunits induces a rearrangement of tapasin from the coreTMD to the N domain of TAP1. Our own studies provide evidence that relocation of tapasin binding within TAP1 is controlled by a process where pre-existing TAP1 chains assemble with newly synthesized TAP2 (K. Keusekotten, R. M. Leonhardt, and M. Knittler, manuscript in preparation). In view of this scenario, the N domain of TAP2 might have a critical role in stabilizing the interaction with chaperones during the structural rearrangement of the tapasin-docking site within TAP1.
The expression level of TAP1 seems to control the amount of stable heterodimeric TAP (34) . TAP1 expression in turn depends on the ability of tapasin to interact with TAP. This becomes evident by a dramatic decrease (up to 100-fold) in the steady state levels of TAP1 in cells that are tapasin deficient or express tapasin mutants that fail to associate with TAP (4, 7). However, the steadystate level of 1⌬N is not affected when compared with TAP1, irrespective whether it is expressed as single chain or in conjunction with TAP2 (Figs. 1B and 5A ). This suggests that stabilization of TAP1 occurs via tapasin-binding to the coreTMD and therefore most likely takes place before and/or during the biosynthetic assembly of the transporter.
Repeated transfection experiments failed to generate T2 cell lines stably coexpressing 1⌬N and 2⌬N. That Koch et al. (8) observed nothing comparable in baculovirus-infected insect cells might be due to the fact that they used a transient overexpression system. Nevertheless, head-to-tail fusion of 1⌬N and 2⌬N linked by the connector region of MDR1b allows stable expression of a transporter lacking both N domains. The transport activity of the tandem TAPs (Fig. 3D) demonstrates that the fused TAP subunits can form the same functional interfaces as they do in heterodimeric TAPwt. This suggests that the structural organization and pairing of the TMDs and nucleotide-binding domains (NBDs) is highly conserved between "tandem-" and "two chain"-ATP-binding cassette transporters. The connector region of MDR1 acts as a flexible linker that allows proper folding, pairing, and coordinated interaction of the two homologous halves as mutations in this region affect protein stability and transport activity (35) . Thus, although clearly not essential for the expression of single TAP chains (Fig. 5A) or the formation of a functional translocation pore (Fig. 3D) , the N domains of TAP may be part of a structural unit that analogous to the connector region is critical for the efficiency of transporter biogenesis by reducing the risk of misassembly, proteolytic degradation, or accumulation of celltoxic aggregates.
Characterization of the MHC I presentation pathway in T2(1-2⌬N) shows that in a situation where the quality control in the PLC fails stabilization of ER-exported MHC I occurs during transport to the plasma membrane (Fig. 6 ). Similar observations were also reported for tapasin-deficient cells (6) . However, it should be noted that based on previous evidence of MHC I-specific differences in tapasin dependence, the extent and nature of post-ER stabilization may be allele-specific (36, 37) . Our studies suggest that post-ER stabilization of the tapasin-dependent allele HLA-B5 requires proprotein convertase (pPC) activity, but not endocytic recycling and/or endosomal processing (Fig. 7B) . Low-affinity peptide ligands tend to dissociate from MHC I at acidic pH conditions corresponding to the TGN (determined to be ϳ5.0) (26) . Furthermore, other studies (38) indicate that at an acidic pH ϳ5.0 MHC I molecules are peptide-receptive and can perform efficient peptide exchange. Because pPCs, e.g., furin, are active in the TGN (9), we speculate that stabilization of suboptimally loaded MHC I occurs via exchange of bound peptides for ones that originate from the proteolytic activity of furin or furin-related proteases. However, we consider it unlikely that the peptide pool to which pPC-activity contributes has a higher affinity for MHC I as the peptides generated by the proteasome. It is more likely that the acidic environment in the TGN confers high stringency on MHC I loading and allows only optimal peptide ligands to bind. Thus, we propose that the TGN serves as a post-ER "checkpoint" of MHC I processing that rescues unstable MHC I complexes, which otherwise have a reduced chance to survive on the cell surface. Because MHC I ligands are much shorter in length than the propeptides liberated by pPCs, further processing by other proteases would be required. Carboxypeptidases, which reside in the TGN, may function in the generation of MHC I binding peptides after processing by pPC activity (10) . It is interesting to note that a plethora of viral proteins is processed by members of the pPC family (39) . Because evasion strategies of some viruses target tapasin-mediated peptide optimization and cause the generation of unstable MHC I molecules (40) , the furin-dependent rescue of MHC I complexes could be part of a cellular counterstrategy that undermines viral efforts to block the Ag presentation machinery.
Our current interest concentrates on the molecular mechanisms and the in vivo-relevance of the pPC-dependent MHC I presentation. So far, 7 different members of the pPC family have been identified (9) . Although HDA is known to have a strong inhibitory effect on furin-activity (28) our studies (Fig. 7B ) do not exclude a proteolytic contribution of other furin-related pPCs in this pathway. Of the known pPCs only four, namely furin, PC7, PC5, and PACE4 show a broad tissue distribution (9) . Our own experiments show that only PC7 and furin, which can both be inhibited by polyarginines (41) , are expressed at significant levels in T2 cells (data not shown). Thus, in future studies it will be of great interest to see whether furin, PC7 or both are involved in the post-ER stabilization of MHC I and what kind of peptide ligands participates in the proposed reloading process.
